Bronstein, Gewirtz & Grossman, LLC Investigates Potential Securities Class Action against Sharecare Inc.
New York, NY – February 12, 2025
Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, is investigating potential claims on behalf of purchasers of Sharecare Inc. (“Sharecare” or “the Company”) (NASDAQ: SHCR). The investigation concerns whether Sharecare and certain of its officers and directors have violated the federal securities laws.
Background on Sharecare Inc.
Sharecare Inc. is a digital health company that provides personalized health and wellness solutions. Its flagship product, the Sharecare platform, connects users with healthcare professionals, offers personalized health and wellness programs, and provides access to health information and resources. The Company went public via a SPAC merger on May 10, 2023.
The Allegations
The investigation focuses on whether Sharecare and its executives made false and misleading statements regarding the Company’s business, operations, and financial condition. Specifically, the firm is looking into:
- The accuracy of Sharecare’s financial statements and projections;
- The adequacy of the Company’s internal controls;
- The impact of competition on Sharecare’s business;
- The Company’s revenue recognition practices;
What This Means for Investors
If you purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, you may be able to participate in a securities class action against the Company. The investigation seeks to recover damages for investors’ losses. To learn more and assist the investigation, visit bgandg.com/SHCR.
Implications for the World
The investigation into Sharecare could potentially impact the digital health industry as a whole. If it is found that Sharecare and its executives made false or misleading statements, it could lead to increased scrutiny of other digital health companies. This could result in increased regulation, investor skepticism, and potential legal action against other players in the industry.
Conclusion
Bronstein, Gewirtz & Grossman, LLC is dedicated to ensuring that investors receive the compensation they are entitled to. If you purchased Sharecare securities prior to May 10, 2023, and believe that you may have been impacted by the alleged misconduct, we encourage you to visit bgandg.com/SHCR to learn more about the investigation and how to assist. The firm takes all potential claims seriously and is committed to pursuing justice for its clients.
This is not a solicitation for investment or an offer to provide legal services. Please note that class action investment lawsuits result in a recovery by participants only if and when a settlement or recovery is made. Past results do not guarantee or predict a similar outcome in any future cases.
